Top Markets
Coin of the day
Pascal Biosciences Inc. Pascal Biosciences Inc.

Pascal Biosciences Inc.

PSCBF
Rangering i aksjer #37975
Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to... Pascal Biosciences Inc. is an innovative biopharmaceutical firm dedicated to discovering and advancing therapeutic solutions for oncology and bolstering immune system function. The company's robust pipeline includes several key candidates: PAS-403, a potent mitosis inhibitor designed to impede cancerous cell division, specifically targeting glioblastoma and secondary brain tumors; and PAS-393, an immunomodulatory cannabinoid developed to enhance the immune system's recognition of tumor cells when utilized alongside checkpoint inhibitor therapy. Furthermore, Pascal is progressing a specialized antibody therapy aimed at B-cells, intended for conditions like acute lymphoblastic leukemia and various B-cell lymphomas. The company is also investigating cannabinoid-derived products as potential treatments for COVID-19. To support its research, Pascal Biosciences maintains an exclusive licensing agreement with the University of Washington for a cannabinoid-based therapeutic against glioblastoma multiforme and brain metastases. It also benefits from a collaborative research partnership with SoRSE Technology Corporation, focused on advancing PAS-393 toward clinical trials. Founded in 2011, the company operates from its headquarters in Seattle, Washington.
Aksjekurs
$0.1
Sist synkronisert: 2024-06-18
Markedsverdi
$1.31M
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Pascal Biosciences Inc. (PSCBF)

Kategori

Antall utestående aksjer for Pascal Biosciences Inc. (PSCBF)
Antall utestående aksjer per February 2024: 38.14M
Ifølge Pascal Biosciences Inc. sine siste økonomiske rapporter og aksjekurs er antall utestående aksjer nå 38.14M. Ved slutten av November 2022 hadde selskapet 13.11M utestående aksjer. Antallet utestående aksjer påvirkes vanligvis av aksjesplitt og tilbakekjøp.
Historikk over utestående aksjer for Pascal Biosciences Inc. (PSCBF) fra 2019 til 2026
Utestående aksjer ved utgangen av hvert år
År Utestående aksjer Endre
2026 (TTM) 38.14M 62.10%
2023 23.53M 79.48%
2022 13.11M 3.25%
2021 12.70M 14.59%
2020 11.08M 5.23%
2019 10.53M 0.00%
Utestående aksjer for lignende selskaper eller konkurrenter
Selskap Utestående aksjer Forskjell Land
253.90M 565.70%
US
62.19M 63.04%
NL
- -
CH
- -
KR
0.00 -100.00%
BE